Riskpilot← Back to searchSign inGet full accessSTOKKE DYREKLINIKK AS
ASActiveOrg 895505692Nygaards Alle 4E, 3160 StokkeVeterinary activities · NACE 7500Est. 20108 employeeswww.stokkedyreklinikk.no
Revenue 2024
NOK 10M
+13% vs 2023
EBITDA margin
6.8%
-37% vs 2023
Equity ratio
34.6%
Financial strength
Net profit 2024
NOK 405K
-41% vs 2023
| Revenue | NOK 10M | +13% |
| EBITDA | NOK 683K | -37% |
| Net profit | NOK 405K | -41% |
| Total assets | NOK 3,2M | +8% |
| Equity | NOK 1,1M | -10% |
| Employees | 8 | — |
Legal name
STOKKE DYREKLINIKK AS
Org number
895505692
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
1. juni 2010
Share capital
NOK 100 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Veterinærvirksomhet og hva herved står i forbindelse. Selskapet kan også investere i aksjer og andre selskaper og tilsvarende investeringer.
Address
Nygaards Alle 4E, 3160 Stokke
Phone
+4733337730
Email
post@stokkedyreklinikk.no
Website
www.stokkedyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 381 | 9 059 | 9 692 | 8 806 | 9 989 |
| Staff expenses | −4 097 | −4 759 | −5 003 | −4 114 | −5 432 |
| EBITDA | 702 | 970 | 935 | 1 079 | 683 |
| Depreciation & amort. | −212 | −224 | −271 | −210 | −185 |
| EBIT | 490 | 746 | 664 | 869 | 499 |
| Net financials | 4 | 7 | 4 | 21 | 38 |
| Profit before tax | 494 | 753 | 667 | 890 | 537 |
| Tax | 108 | 167 | 155 | 207 | 132 |
| Net profit | 386 | 586 | 513 | 683 | 405 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 250 | 3 109 | 2 311 | 2 930 | 3 150 |
| Equity | 1 044 | 1 381 | 893 | 1 211 | 1 090 |
| Long-term debt | 1 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 205 | 1 729 | 1 418 | 1 719 | 2 060 |
| Total debt | 1 206 | 1 729 | 1 418 | 1 719 | 2 060 |
EBITDA margin
6.8%
This company
15.8%
Market median
-57% vs market
20202024
Equity ratio
34.6%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
37.2%
This company
18.4%
Market median
+102% vs market
20202024
Net profit margin
4.1%
This company
8.1%
Market median
-49% vs market
20202024
Asset turnover
3.17×
This company
1.12×
Market median
+183% vs market
20202024
Debt / equity
1.89×
This company
0.62×
Market median
-205% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KJ Chief Executive Officer | Chief Executive Officer | 2010 |
BW Deputy Member | Deputy Member | 2010 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kajafo Holding As
STOKKE DYREKLINIKK AS Board members of STOKKE DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Jannicke Fonnum | Chief Executive Officer | 0 companies |
| Bjørnar Werner Jakobsen | Deputy Member | 0 companies |